Suppr超能文献

右美托咪定引起的术后重症监护病房药物热

Postoperative intensive care unit drug fever caused by dexmedetomidine.

作者信息

Okabe Tadashi, Takeda Shinhiro, Akada Shinji, Hongo Takashi, Sakamoto Atsuhiro

机构信息

Department of Anesthesiology and Intensive Care Medicine, Nippon Medical School, Tokyo, Japan.

出版信息

Anesth Analg. 2009 May;108(5):1589-91. doi: 10.1213/ane.0b013e31819f1985.

Abstract

Dexmedetomidine hydrochloride is a potent, highly selective alpha-2 adrenergic receptor agonist, broadly used as a sedative drug in intensive care units. We describe the case of a 59-yr-old patient who experienced drug fever caused by dexmedetomidine hydrochloride. The patient was transferred to the intensive care unit with an abdominal aortic aneurysm rupture. After initiation of sedation with dexmedetomidine hydrochloride, he developed pyrexia of more than 39 degrees C. This symptom improved rapidly 7 h after stopping dexmedetomidine hydrochloride. Other possible causes (such as infection) were sequentially eliminated.

摘要

盐酸右美托咪定是一种强效、高选择性的α-2肾上腺素能受体激动剂,在重症监护病房广泛用作镇静药物。我们描述了一例59岁患者因盐酸右美托咪定引起药物热的病例。该患者因腹主动脉瘤破裂被转入重症监护病房。在用盐酸右美托咪定开始镇静后,他出现了体温超过39摄氏度的发热症状。在停用盐酸右美托咪定7小时后,该症状迅速改善。其他可能的原因(如感染)被逐一排除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验